Back to Search
ARNOLD FREEDMAN, MD
MD
Medical Oncology Physician
NPI: 1245207828IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
47330(MA)
Education
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
Class of 1979
Research & Publications (20)
Placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T and granulocyte-macrophage colony-stimulating factor after rituximab in patients with follicular lymphoma.
PMID 19414675·J Clin Oncol·2009
3-trial
Non-transplant-related treatment options in follicular lymphoma.
PMID 16399586·Biol Blood Marrow Transplant·2006
6-review
Biology and management of histologic transformation of indolent lymphoma.
PMID 16304397·Hematology Am Soc Hematol Educ Program·2005
8-other
Colorectal cancer risk prediction tool for white men and women without known susceptibility.
PMID 19114701·J Clin Oncol·2009
8-other
Modeling the effects of anthropogenic habitat change on savanna snake invasions into African rainforest.
PMID 18778269·Conserv Biol·2009
7-preclinical
Cancer risk prediction models: a workshop on development, evaluation, and application.
PMID 15900041·J Natl Cancer Inst·2005
8-other
Urologic diseases in North America Project: trends in resource utilization for urinary tract infections in children.
PMID 15711347·J Urol·2005
8-other
Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention.
PMID 12671020·J Natl Cancer Inst·2003
8-other
US physicians' attitudes toward genetic testing for cancer susceptibility.
PMID 12794694·Am J Med Genet A·2003
8-other
Preventive care for the elderly. Do family physicians comply with recommendations of the Canadian Task Force on Preventive Health Care?
PMID 10690491·Can Fam Physician·2000
4-observational
A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas.
PMID 19344412·Br J Haematol·2009
3-trial
Selection of drug-resistant HIV-1 during the early phase of viral decay is uncommon in treatment-naïve patients initiated on a three- or four-drug antiretroviral regimen including lamivudine.
PMID 19031460·J Med Virol·2009
8-other
Validation of a colorectal cancer risk prediction model among white patients age 50 years and older.
PMID 19114700·J Clin Oncol·2009
4-observational
Conceptual problems in laypersons' understanding of individualized cancer risk: a qualitative study.
PMID 19250148·Health Expect·2009
8-other
Landscape genetics of California mule deer (Odocoileus hemionus): the roles of ecological and historical factors in generating differentiation.
PMID 19302356·Mol Ecol·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 44 BINNEY STREET, ROOM D1B30 DFCI DANA FARBER CANCER INSTITUTE
BOSTON, MA 02115 - Phone
- (617) 632-4894
Quick Facts
- NPI
- 1245207828
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 47
- Publications
- 20
Are you this provider?
Claim Your Profile